6 Stocks To Watch: Co-Diagnostics, Inovio, Progyny, Translate Bio, Upwork...
Harry Boxer | May 14, 2020 12:13AM ET
1. Co-Diagnostics (NASDAQ:CODX) had an exceptional day on Wednesday. I have been telling you that this swing was ready to take off and it did. Once it got through the level around 13-13 1/2, it popped, stalled, and then on Wednesday it exploded 6.42, or 38%, to 23.42, after reaching a multi-week and session high of 23.50, on 21.3 million shares traded. It was up an additional 3.33 to 26.75 in after-hours. It looks like it might accelerate here. I want to see if it will run up to the high 30’s, low 40’s next.
2. Inovio Pharmaceuticals (NASDAQ:INO) extended its move for the fourth day in a row on Wednesday, gaining 47 cents, or 3.64%, to 13.37, with a session high of 13.85, on 38.6 million shares traded, and another 11 cents in after-hours. It looks to me like it’s going to make a run at the 16-16 1/2 range short term.
3. Progyny, (NASDAQ:PGNY), company specializing in fertility and family building management and benefits solution, broke out of a base on Wednesday with a breakaway gap and soared 5.64, or 27.5%, to 26.13, with a session high of 27.49, on 5.2 million shares traded, and another 27 cents in after-hours. That’s the biggest volume traded since its IPO days back in October. Some resistance occurred around 29, which is the near-term target, and a secondary target is in the mid 30’s may be doable.
4. Translate Bio (NASDAQ:TBIO) has been breaking out of a base, and formed a big engulfing bar on Wednesday, advancing 2.00, or 14.6%, to 15.67, with a multi-week and session high of 15.95, on nearly a million shares traded, and an additional 24 cents higher in after-hours. I think this stock has designs on higher levels. The parallel angle channel tells me that this might be an 18-19-dollar stock.
5. Upwork (NASDAQ:UPWK), an online website for freelancers and agencies searching for employment and employees, exploded on Tuesday and followed through on Wednesday to right at the gap at resistance, jumping 1.29, or 10 1/2%, to 13.58, with a session high of 13.60, on 8.3 million shares traded, and then made a big thrust to 14 1/2 in after-hours. We’ll be watching this one on Thursday for a move that might test 15 1/2.
6. vTv Therapeutics (NASDAQ:VTVT) broke out on Tuesday and closed above the breakout point, and on Wednesday, it reached secondary resistance and blew through that, popping 63 cents, or 25%, to 3.19, with a session high of 3.31, on 2.7 million shares traded and another 10 cents higher in after-hours. My target now is 4-4 1/4. Secondary target is up around 6.
Stocks on the long side
Altimmune, Inc. (NASDAQ:ALT), Co-Diagnostics, Inc. (CODX), Creative Realities, Inc. (NASDAQ:CREX), Immune Therapeutics, Inc. (IMUN), Inovio Pharmaceuticals, Inc. (INO), Moderna, Inc. (NASDAQ:MRNA), Natural Grocers (NYSE:NGVC) by Vitamin Cottage, Inc. (NGVC), NanoViricides, Inc. (NNVC), Overstock.com, Inc. (NASDAQ:OSTK), Progyny, Inc. (PGNY), PGT Innovations, Inc. (NYSE:PGTI), Revolve Group, Inc. (NYSE:RVLV), Translate Bio, Inc. (TBIO), United Natural Foods, Inc. (NYSE:UNFI), Upwork Inc. (UPWK), VectoIQ Acquisition Corp. (VTIQ), and vTv Therapeutics Inc. (VTVT).
Get The News You Want
Watch video here...
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.